Home » Japan Agrees to Measures Aimed at Expanding Access to New Treatments
Japan Agrees to Measures Aimed at Expanding Access to New Treatments
August 16, 2006
Japan’s efforts to improve pharmaceutical regulation and speed the introduction of novel therapies include steps to streamline the new drug review process and enhance U.S. manufacturers’ dialogue with Japanese regulators, according to a recent report on the U.S.-Japan Regulatory Reform and Competition Initiative.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor